Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors.

MLA

Pedraza, Arevalo, Sergio, et al. “Epigenetic and Post‐transcriptional Regulation of Somatostatin Receptor Subtype 5 (SST5) in Pituitary and Pancreatic Neuroendocrine Tumors.” Molecular Oncology, vol. 16, no. 3, Feb. 2022, pp. 764–79. EBSCOhost, https://doi.org/10.1002/1878-0261.13107.

APA

Pedraza, A. S., Ibáñez, C. A., Blázquez, E. R., Branco, M. R., Vázquez, B. M. C., Herrera, M. A. D., Venegas, M. E., Serrano, B. R., Arjona, S. Á., Gálvez, M. M. A., Korbonits, M., Soto, M. A., Gahete, M. D., Charalambous, M., Luque, R. M., & Castaño, J. P. (2022). Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors. Molecular Oncology, 16(3), 764–779. https://doi.org/10.1002/1878-0261.13107

Chicago

Pedraza, Arevalo, Sergio, Costa, Alejandro Ibáñez, Encinas, Ricardo Blázquez, Miguel R. Branco, Borrego, Mari C. Vázquez, Martínez, Aura D. Herrera, Moreno, Eva Venegas, et al. 2022. “Epigenetic and Post‐transcriptional Regulation of Somatostatin Receptor Subtype 5 (SST5) in Pituitary and Pancreatic Neuroendocrine Tumors.” Molecular Oncology 16 (3): 764–79. doi:10.1002/1878-0261.13107.